Acute Promyelocytic Leukaemia PI-APML #1 Protocol
Date last published:
Use of this protocol is at the discretion of the treating physicians in Fiji depending on the local perception of their ability to manage therapy delivery and supportive care in the local setting.
This document is only valid for the day on which it is accessed. Please read our .
Child cancer
Use of this protocol is at the discretion of the treating physicians in Fiji depending on the local perception of their ability to manage therapy delivery and supportive care in the local setting.
Access the pdf PI-APML #1 Protocol here.
Conflict of Interest Statement
The authors state they have no financial or other interest in the production of this protocol which is done in the interests of public good and to support the established twinning arrangements between the two New Zealand Paediatric oncology centres and colleagues in the Pacific.